Mankind Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has submitted a routine compliance certificate to the stock exchanges from its Registrar and Share Transfer Agent, KFin Technologies. The certificate confirms that no requests for dematerialisation or rematerialisation of shares were received during the quarter ended December 31, 2025. This is a standard quarterly filing required under SEBI's Depositories Regulations. The letter was signed by Kishore B, Senior Manager at KFin Technologies, and submitted by Hitesh Kumar Jain, Company Secretary of Mankind Pharma.
This is a routine regulatory compliance filing with no material impact on the stock price or shareholders. It simply confirms there was no share conversion activity during the quarter and indicates the company is meeting its listing obligations on time.